114 Patients Infected With Potentially Deadly Bacteria In Osaka Medical Center
This article was originally published in PharmAsia News
A total of 114 people have been infected with a metallo-beta-lactamase producing bacteria in Japan in 2010-2014, the National Hospital Organization Osaka Medical Center announced at a press conference on March 20.
You may also be interested in...
Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.
Keeping Track: US FDA Set For Speed With Approvals Of Inqovy, Rukobia, Dojolvy, Phesgo; Keytruda Loses Chance At AA In HCC
The latest drug development news and highlights from the Pink Sheet’s FDA Performance Tracker.
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.